✨ Your Portfolio is fetched and updated from zerodha.
Nano Miscellaneous

Balaxi Pharmaceuticals Ltd.

BALAXI

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹238 Cr.
P/E
12.62

Balaxi Pharmaceuticals Ltd.

  • Balaxi Pharma.
  • Ambalal Sarabhai Ent
  • Vaidya Sane Ayur Lab

FAQs on Balaxi Pharmaceuticals Ltd. Shareprice

Balaxi Pharma. has given lower returns compared to its competitors.
Balaxi Pharma. has grown at ~-27.72% over the last 3yrs while peers have grown at a median rate of 14.62%

Balaxi Pharma. is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Balaxi Pharma. is 13.13, while 3 year average PE is 9.21.
Also latest EV/EBITDA of Balaxi Pharma. is 8.32 while 3yr average is 10.17.

View FAQ's On Business

Growth Table

  • Balaxi Pharmaceuticals Ltd.
  • Ambalal Sarabhai Ent
  • Vaidya Sane Ayur Lab

Balance Sheet

  • Balaxi Pharmaceuticals Ltd.
  • Ambalal Sarabhai Ent
  • Vaidya Sane Ayur Lab

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Balaxi Pharmaceuticals Ltd.
  • Ambalal Sarabhai Ent
  • Vaidya Sane Ayur Lab

Cash Flow

  • Balaxi Pharmaceuticals Ltd.
  • Ambalal Sarabhai Ent
  • Vaidya Sane Ayur Lab

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Balaxi Pharmaceuticals Ltd.
  • Ambalal Sarabhai Ent
  • Vaidya Sane Ayur Lab

Quarterly Results

  • Balaxi Pharmaceuticals Ltd.
  • Ambalal Sarabhai Ent
  • Vaidya Sane Ayur Lab

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Balaxi Pharmaceuticals Ltd. Financials

Balance sheet of Balaxi Pharma. is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Balaxi Pharma. is increasing.
Latest net debt of Balaxi Pharma. is -₹26.39 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹105.14 Crs.

The profit is oscillating.
The profit of Balaxi Pharma. is ₹18.88 Crs for TTM, ₹27.67 Crs for Mar 2025 and -₹7.31 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Balaxi Pharma. latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech